Effects of nocturnal doses of mirtazapine and mianserin on sleep and on daytime psychomotor and driving performance in young, healthy volunteers

Human Psychopharmacology

Volumn 13, Issue SUPPL. 2, 1998, Pages

  Ramaekers, J G ^a   Muntjewerff, N D ^a   Van Veggel, L M A ^a   Uiterwijk, M M C ^a   O'Hanlon, J F ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Driving performance; Impairment; Mianserin; Mirtazapine; Psychomotor function; Sleep

Indexed keywords

HISTAMINE H1 RECEPTOR ANTAGONIST; MIANSERIN; MIRTAZAPINE; SEROTONIN RECEPTOR AFFECTING AGENT;

ADULT; ALERTNESS; ARTICLE; BEER; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DROWSINESS; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN EXPERIMENT; LETHARGY; MALE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE; SLEEP;

EID: 0031762660     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(1998110)13:2+3.0.CO;2-8     Document Type: Article

References (28)

1. Bond, A. and Lader, M. (1974). The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology 47, 211-218.
2. Borkenstein, R. F., Crowther, R. F., Schumate, R. P., Ziel, W. B. and Zylman, R. (1964). The Role of the Drinking Driver in Traffic Accidents. Department of Police Administration, Indiana University, Bloomington.
3. Curran, H. V. and Lader, M. (1986). The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects. Eur. J. Clin. Pharmacol., 29, 601-607.
4. Data on file, NV Organon, Oss, The Netherlands.
5. De Boer, T. (1996). The pharmacologie profile of mirtazapine. J. Clin. Psychiatry, 57(suppl. 4), 19-25.
6. A mediated serotonergic neurotransmission. CNS Drugs, 4(suppl. 1), 18-28.
7. Delbressine, L. P. and Vos, R. M. (1997). The clinical relevance of preclinical data: mirtazapine, a model compound. J. Clin. Psychopharmacol., 17(suppl. 2), 29-33.
8. Jex, H. R., McDonnel, J. D. and Phatak, A. V. (1966). Critical tracking task for manual control research. IEEE Trans. Hum. Fac. En., 7, 138-146.
9. Kelder, J., Funke, C., De Boer, T., Delbressine, L., Leysen, D. and Nicholson, V. (1997). A comparison of the physicochemical and biological properties of mirtazapine and mianserin. J. Pharm. Pharmacol., 49, 403-411.
10. Louwerens, J. W., Brookhuis, K. A. and O'Hanlon, J. F. (1986). Several antidepressants' acute effects upon actual driving performance and subjective mental activation. In Drugs and Driving, O'Hanlon, J. F. and De Gier, J. J. (Eds), Taylor and Francis, London.
11. Louwerens, J. W., Gloerich, A. B. M., de Vries, G., Brookhuis, K. A. and O'Hanlon, J. F. (1987). The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. In Alcohol, Drugs and Traffic Safety - T86, Noordzij, P. C., Roszbach, R. (Eds), Elsevier, Amsterdam.
12. Mackworth, N. H. (1950). Researches on the Measurement of Human Performance. Medical Research Council special report no. 268. HMSO, London.
13. Mattila, M. J., Liljequist, R. and Seppällä, T. (1978). Effects of amitriptyline and mianserin on psychomotor skills and memory. Br. J. Clin. Pharmacol., 5(suppl.), 53-59.
14. Mattila, M., Mattila, Mj., Vrijmoed-De Vries, M. and Kuitunen, T. (1989). Actions and interactions of psychotropic drugs on human performance and mood: single doses of ORG 3770, amitriptyline, and diazepam. Pharmacology & Toxicology, 65, 81-88.
15. Mulder-Hajonides van der Meulen, W. R. E. H. (1981). Measurements of subjective sleep quality. Proceedings of International European Sleep Congress. Elsevier, Amsterdam.
16. O'Hanlon, J. F., Haak, T. W., Blaauw, G. J. and Riemersma, J. B. J. (1982). Diazepam impairs lateral position control in highway driving. Science, 217, 79-81.
17. Ramaekers, J. G., Swijgman, H. F. and O'Hanlon, J. F. (1992). Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacology 106(suppl.), 62-67.
18. Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K. and Melton, L. F. (1987). Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine, 316, 363-369.
19. R) on performance occurs during 19 days of dosing, beginning at 15 mg nocte and rising to 45 mg nocte. Technical report. Institute for Human Psychopharmacology, University of Limburg, Netherlands.
20. Roehrs, T., Claiburue, R., Knox, M. and Roth, T. (1993). Effects of ethanol, diphenhydramine and triazolam after a nap. Neuropsychopharmacology, 9, 239-245.
21. Ruigt, G. S. F., Kemp, B., Groenhout, C. M. and Kamphuisen. H. A. C. (1990). Effect of the anti-depressant ORG 3770 on human sleep. Eur. J. Clin. Pharmacol., 38, 551-554.
22. Seppällä, T. (1977). Psychomotor skills during acute and two-week treatment with mianserin (org GB 94) and amitriptyline, and their combined effects with alcohol. Ann. Clin. Res., 9, 66-72.
23. Timmer, C. J., Lohmann, A. M. and Mink, C. P. A. (1995). Pharmacokinetic dose-proportionality study atsteady state of mirtazepine from Remeron® tablets. Human Psychopharmacology, 10(2), 97-106.
24. Vermeeren, A., Ramaekers, J. G., van Leeuwen, C. J. and O'Hanlon, J. F. (1998). Residual effects on actual car driving of evening dosing of chlorpheniramine 8 and 12 mg when used with terfenadine 60 mg in the morning. Human Psychopharmacology, 13, S79-S86.
25. R tablets aftersingle and multiple dosing. Human Psychopharmacol., 10(2), 83-96.
26. Vuurman, F. P. M. and O'Hanlon, J. F. (1991). An improved method for measuring drug effects on the critical fusion frequency (abstract). European Neuropharmacology, 1(3), 467.
27. Vuurman et al. (1994).
28. Winer, B. J. (1962). Statistical Principles in Experimental Design. McGraw-Hill, New York.